natrunix
natrunix: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| XBiotech Inc. (XBIT) | Phase 2 |
Clinical Trials (1)
Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Efficacy and Safety of Vilamakitug in Participants With Active Axial Spondyloarthritis
Frequently asked questions
Who is developing natrunix?
natrunix is being developed by XBiotech Inc..
How many clinical trials involve natrunix?
BioSniper tracks 1 clinical trial involving natrunix.
Get deeper analysis on natrunix
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis